Cell line · CVCL_0236
Calu-6
Cancer cell line, Homo sapiens. Lung adenocarcinoma. 53 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Calu-6. Cell lines, record CVCL_0236. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0236
On this page
Cell line
As Cellosaurus gives it.
- Name
- Calu-6
- Accession
- CVCL_0236
- RRID
- RRID:CVCL_0236
- Synonyms
- CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 61Y
- Category
- Cancer cell line
- Diseases
- Lung adenocarcinoma (NCIt C3512)
- Derived from
- Pleural effusion (metastatic)
- Cell type
- Epithelial cell
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers53
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CGM23 corresponds to a pan-coronavirus lipopeptide inhibitor potently inhibiting virion fusion. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti-PD-1 Therapy. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LAT1/SLC7A5-mediated amino acid uptake is regulated by redox signals triggered by formyl-peptide receptor 2. | FEBS J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Memory T-Cell Phenotype in Cutaneous T-Cell Lymphoma Is Modified by Germline Gene Gametocyte Specific Factor 1. | Exp Dermatol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Discovery and characterization of a novel telomerase alternative splicing isoform that protects lung cancer cells from chemotherapy induced cell death. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pretargeted Trop-2 ImmunoPET for Rapid, Selective Detection of Pancreatic Tumors. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2. | Elife | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 53
See all 53 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Calu6 Krev-2 | CVCL_D4Y3 | Cell lines | |
| Derived from it | Calu6 Krev-4 | CVCL_D4Y4 | Cell lines | |
| Derived from it | Calu6 Krev-7 | CVCL_D4Y5 | Cell lines | |
| Derived from it | Calu6 Krev-8 | CVCL_D4Y6 | Cell lines | |
| Derived from it | Calu6 Krev-9 | CVCL_D4Y7 | Cell lines | |
| Derived from it | Calu6/Beta2 | CVCL_C8GA | Cell lines | |
| Derived from it | Caov-2 | CVCL_6861 | Has a recorded problem | Cell lines |
| Derived from it | rCalu-6 | CVCL_F0Q6 | Cell lines |
Cell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-56 | ATCC | |
| CLS | 300135 | CLS | |
| CancerTools | 161924 | CancerTools | |
| DSMZ | ACC-734 | DSMZ | |
| ICLC | HTL97003 | ICLC | |
| KCLB | 30056 | KCLB | |
| NCBI_Iran | C431 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0236
GET https://conductscience.org/api/cell-lines/v1/CVCL_0236/papers?page=2